학술논문
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2021, Vol. 17 Issue 3, p723-730, 8p, 1 Diagram, 5 Charts, 2 Graphs
Subject
Language
ISSN
21645515